Proto Labs Inc (PRLB) Jumps 13.6% on February 04

Equities Staff  |

Proto Labs Inc (PRLB) was among the biggest gainers on the Russell 2000 for Thursday February 04 as the stock popped 13.6% to $60.05, representing a gain of $7.19 per share. Some 795,000 shares traded hands on 7,006 trades, compared with an average daily volume of 224,150 shares out of a total float of 26.16 million. The stock opened at $54.28 and traded with an intraday range of $61.59 to $54.28.

After today's gains, Proto Labs Inc reached a market cap of $1.57 billion. Proto Labs Inc has had a trading range between $79.95 and $51.61 over the last year, and it had a 50-day SMA of $61.42 and a 200-day SMA of $67.12.

The stock has a P/E Ratio of 31.9.

Proto Labs Inc is a manufacturer of custom parts for prototyping and short-run production. It utilizes computer numerical control (CNC) machining and injection molding to manufacture custom parts.

Proto Labs Inc is based out of Maple Plain, MN and has some 1,077 employees. Its CEO is Victoria M. Holt.

For a complete fundamental analysis analysis of Proto Labs Inc, check out’s Stock Valuation Analysis report for PRLB. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Dr Oliver Krause Founder Untitled Inc Part 2

Matt Bird sits down with Dr Oliver Krause, Founder Untitled Inc, in part 2 of this 2 part interview at the World Economic Forum at Davos 2019

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…